Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AXA Introduces "Better She" 2023-11-14 12:12
George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials 2023-11-14 10:48
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO 2023-11-14 08:27
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam® 2023-11-14 06:33
Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety 2023-11-14 03:00
SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma 2023-11-14 02:00
More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds 2023-11-14 00:36
Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries 2023-11-13 22:15
LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE 2023-11-13 22:00
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care 2023-11-13 22:00
OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002 2023-11-13 22:00
Agora Announces RTE Telehealth, A Webinar Exploring the Impact of AI and AR/VR in Virtual Healthcare 2023-11-13 22:00
Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update 2023-11-13 21:30
DFS GROUP Collaborates with Galaxy Macau to Spread Positive Energy with Wellness 2023-11-13 21:15
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE 2023-11-13 21:00
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC) 2023-11-13 20:20
1 135 136 137 138 139 1567